Lipitor Tablet, Film Coated
Product Images NDC 58151-157

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lipitor (NDC 58151-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Chemical structure of atorvastatin calcium, the active ingredient in Lipitor, showing its molecular arrangement including calcium ions and associated molecular groups.*

FDA Label Image

Effect Of Lipitor 10 mg/day On Cumulative Incidence Of Non-fatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Image 02)

A cumulative incidence graph comparing atorvastatin and placebo over 3.5 years. The y-axis represents cumulative incidence percentage, and the x-axis represents time in years. The graph includes hazard ratio and p-value statistics indicating lower incidence with atorvastatin compared to placebo.*

FDA Label Image

Effect Of Lipitor 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) In Cards (Image 03)

A cumulative hazard plot comparing placebo and atorvastatin over a five-year follow-up period. The x-axis represents time in years to the first primary endpoint, and the y-axis shows the cumulative hazard percentage. Two lines display hazard progression for placebo and atorvastatin groups, with atorvastatin showing a lower cumulative hazard.*

FDA Label Image

Effect Of Lipitor 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Image 04)

A line graph comparing the percentage of subjects experiencing cardiovascular events over five years between two dosages of atorvastatin calcium tablets, 10 mg and 80 mg. The x-axis represents time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. Two lines depict outcomes for the 10 mg dosage (dashed) and the 80 mg dosage (solid).*

FDA Label Image

Lipitor® 10 mg (Image 05)

Label for Lipitor (atorvastatin calcium) tablets, 10 mg strength, film-coated, oral dosage form. The package contains 90 tablets and is labeled for Rx only use. Distributed by Viatris Specialty LLC, Morgantown, WV. Storage instructions indicate controlled room temperature 20-25°C (68-77°F). The label features the Viatris logo and includes an NDC number 58151-155-77.*

FDA Label Image

Lipitor® 20 mg (Image 06)

Label for Lipitor 20 mg film-coated tablets (atorvastatin calcium) by Viatris Specialty LLC. The label indicates a package size of 90 tablets. Storage instructions specify controlled room temperature between 20-25°C (68-77°F). The label includes dosage information and barcodes, with the Viatris logo prominently displayed.*

FDA Label Image

Lipitor® 40 mg (Image 07)

Label of Lipitor 40 mg film-coated tablets by Viatris Specialty LLC. The label shows the brand and generic names, strength (40 mg), dosage form (tablets), quantity (90 tablets), and notes it is Rx only. Storage instructions and distributor information are included.*

FDA Label Image

Lipitor® 80 mg (Image 08)

Packaging label for Lipitor 80 mg film-coated tablets, containing atorvastatin calcium. The label shows 90 tablets per container, distributed by Viatris Specialty LLC, Morgantown, WV. The label includes storage instructions at controlled room temperature (20-25°C) and a note to see package insert for full prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.